Bellerophon Reports 2015 Third Quarter Operational and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Bellerophon Therapeutics (BLPH) Tops Q3 EPS by 8c
November 12, 2015 6:18 AM ESTBellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.86), $0.08 better than the analyst estimate of ($0.94).
For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.
... More